Iovance Biotherapeutics, Inc. (IOVA) earnings

Earnings (net income) · fiscal 2025
-$390.98M

Iovance Biotherapeutics, Inc. (IOVA) reported net income of -$390.98M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$372.18M. Figures as of 18 Nov 2026, 10:46 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2025
-$390.98M
Highest on record
-$15.77Kfiscal 2009
Lowest on record
-$444.04Mfiscal 2023
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Iovance Biotherapeutics, Inc. earnings, in more detail

Across the 18 fiscal years on record (2008–2025), the highest was -$15.77K in fiscal 2009 and the lowest -$444.04M in fiscal 2023.

History · 18 fiscal years

Earnings (net income) by fiscal year

Iovance Biotherapeutics, Inc. earnings, year by year

Iovance Biotherapeutics, Inc. (IOVA) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2025-$390.98M—
2024-$372.18M—
2023-$444.04M—
2022-$395.89M—
2021-$342.25M—
2020-$259.58M—
2019-$197.56M—
2018-$123.58M—
2017-$92.06M—
2016-$52.89M—
2015-$27.66M—
2014-$12.04M—
2013-$25.38M—
2012-$3.31M—
2011-$25.69M—
2010-$1.61M—
2009-$15.77K—
2008-$58.72K—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

More on IOVA

Iovance Biotherapeutics, Inc., figure by figure

Iovance Biotherapeutics, Inc. (IOVA) overview: price, valuation and scorecard

Iovance Biotherapeutics, Inc. earnings: questions and answers

What is Iovance Biotherapeutics, Inc.'s net income?

Iovance Biotherapeutics, Inc. (IOVA) reported net income of -$390.98M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$372.18M.

What are the highest and lowest net income figures on record for Iovance Biotherapeutics, Inc.?

Across the 18 fiscal years on record (2008–2025), the highest was -$15.77K in fiscal 2009 and the lowest -$444.04M in fiscal 2023.

How is Iovance Biotherapeutics, Inc.'s net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement. For Iovance Biotherapeutics, Inc. it is on record here for 18 fiscal years, 2008 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Iovance Biotherapeutics, Inc. (IOVA) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/IOVA/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.